Innovation and worldwide deployment of Precision Oncology were the aspirational goals of Dr. John Mendelsohn, founder and chairman of WIN and Prof. Waun Ki Hong, special advisor to WIN for lung cancer. Their recent deaths leave us deeply saddened.
We are proud to provide leadership to the WIN Consortium as chairman and vice-chairman and are excited about the challenge and privilege to continue the work started by these two great giants in oncology.
We are warmly inviting you to attend the WIN 2019 symposium dedicated to Innovation and global deployment of Precision Oncology.
For the WIN Symposium 2019 we have gathered renowned experts across the world including Jennifer A. Doudna, co-inventor of the gene-editing technology, CRISPR/Cas9, who will present a talk on " rewriting the code of life" and the complex ethics of genetic manipulation. Other speakers will be Jennifer A. Ligibel, Razelle Kurzrock, Apostolia-Maria Tsimberidou, Christophe Le Tourneau, Phillip G. Febbo and Jean-François Martini and many others to discuss both the latest discoveries as well as the real world experience of Precision Oncology.
Your attendance will also be an invaluable opportunity to engage and network with all the different parties attending this year's symposium, from academia, industry, non-profit and patient advocacy.
Richard L. Schilsky
MD, FACP, FSCT, FASCO
Chairman, WIN Consortium, Senior Vice President & Chief Medical Officer, American Society of Clinical Oncology (ASCO)
Vice Chairman, WIN Consortium Head, Medical Oncology Department, Vall d’Hebron Institute of Oncology President, European Society for Medical Oncology (ESMO)